[1] Han X,Zhao L,Mu Y,et al.Undifferentiated high-grade pleomorphic sarcoma of the colon: a rare case report and literature review[J].BMC Gastroenterol,2022,22(1):115.
[2] Alagha O M,Igbokwe A A. Malignant fibrous histiocytoma:between the past and the present[J]. Arch Pathol Lab Med,2008,132(6):1030-1035.
[3] Jo V Y, Fletcher C D. WHO classification of soft tissue tumours: an update based on the 2013(4th) edition [J]. Pathology, 2014, 46 (2): 95-104.
[4] The WHO Classification of Tumours of Editorial Board. WHO classification of soft tissue and bone tumours[M].5th ed.Lyon: IRAC Press, 2020: 1-335.
[5] Augsburger D,Nelson P J,Kalinski T,et al. Current diagnostics and treatment of fibrosarcoma-perspectives for future therapeutic targets and strategies [J].Oncotarget,2017,8 (61): 104638-104653.
[6] Widemann B C, Italiano A. Biology and management of undifferentiated pleomorphic sarcoma myxofibrosarcoma, and malignant peripheral nerve sheath tumors: state of the art and perspectives[J]. J Clin Oncol, 2018, 36(2): 160-167.
[7] 张九龙,熊祚刚,张 峰,等. 未分化多形性肉瘤 MRI 特征及 Ki-67 表达与预后相关性[J]. 实用放射学杂志,2016,32(3):396-399.
[8] 张曙光,于胜吉. 未分化多形性肉瘤的临床研究进展[J]. 癌症进展,2018,16(11):1335.
[9] Heslin M J,Lewis J J,Nadler E,et al. Prognostic factors associated with long-term survival for retroperitoneal sarcoma:implications for management[J]. J Clin Oncol,1997,15(8):2832-2839.
[10] Henderson M T,Hollmig S T. Malignant fibrous histiocytoma:changing perceptions and management challenges[J]. J Am Acad Dermatol,2012,67(6):1335-1341.
[11] Paiva A,Abreu M,Souza M P. Undifferentiated pleomorphic sarcoma[J]. J Oral Maxillofac Pathol,2018,93(1):154-155.
[12] Soccol C R,Bissoqui Bissoqui L Y,Rodrigues C, et al. Pharmacological properties of biocompounds from spores of the lingzhi or reishi medicinal mushroom ganoderma lucidum (Agaricomycetes): a review[J].Int J Med Mushrooms,2016,18(9):757-767.
[13] 秦 葵,钱彦从.灵芝免疫药理究进展[J].解放军药学学报,2003,19(5):360-362.
[14] 齐元富,李秀荣,阎 明,等.灵芝孢子粉辅助化疗治疗消化系统肿瘤的临床观察[J].中国中西医结合杂志,1999,19(9):554-555.
[15] Zhao H,Zhang Q,Zhao L,et al. Spore powder of ganoderma lucidum improves cancer-related fatigue in breast cancer patients undergoing endocrine therapy: a pilot clinical trial[J].Evid Based Complement Alternat Med,2012,2012(1): 809614-809615.